Barclays downgraded Stryker shares, according to a Woodbridge Daily report.
Spinal Tech
Atlas Spine plans to raise money through OfferBoard Securities in Series B financing.
Results from the KAST trial, involving Benvenue Medical's Kiva VCF Treatment System and its efficacy as compared to balloon kyphoplasty, have been published in Spine.
Safe Orthopaedics announced the European launch of its new fenestrated screw.
K2M shares reached $23.89 on April 7, which a new 52-week high for the company, according to an Equities report.
Advertisement
Here are the mergers and acquisitions that took place among spine and orthopedic companies within the last two months.
SpineGuard released their first quarter 2015 financial report.
Zacks updated Orthofix's price target to $36, according to a Legacy report.
Mazor reported three new Renaissance system orders in the first quarter of 2015.
Research and Markets released a report on key material technologies for the next generation of implants.